Chi Sheng Pharma & Biotech , Ltd Accounts Payable

As of the most recent data (June 2026), 4111.TWO shows a accounts payable of $210M. That compares with $130M in the prior-year period — up 60.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4111.TWO's accounts payable is now $210M (was $130M) — a 60.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Chi Sheng Pharma & Biotech , Ltd is outperforming or lagging.

Tracking 4111.TWO's accounts payable over time shows whether Chi Sheng Pharma & Biotech , Ltd is scaling, shrinking, or reshaping that part of the business. The current reading is $210M That compares with $130M in the prior-year period — up 60.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Chi Sheng Pharma & Biotech , Ltd's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $210M) with ownership activity and broader fundamentals.